NP Life Sciences Health Industry Group Inc.

OTCPK:NPLS Stock Report

Market Cap: US$2.3m

NP Life Sciences Health Industry Group Past Earnings Performance

Past criteria checks 0/6

NP Life Sciences Health Industry Group has been growing earnings at an average annual rate of 63.8%, while the Consumer Services industry saw earnings growing at 17.9% annually. Revenues have been growing at an average rate of 92.2% per year.

Key information

63.8%

Earnings growth rate

65.4%

EPS growth rate

Consumer Services Industry Growth20.3%
Revenue growth rate92.2%
Return on equity-17.9%
Net Margin-1.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How NP Life Sciences Health Industry Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:NPLS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230000
30 Sep 230000
30 Jun 230000
31 Mar 230000
31 Dec 220000
30 Sep 220000
30 Jun 220000
31 Mar 220000
31 Dec 210000
30 Sep 210000
30 Jun 210000
31 Mar 210000
31 Dec 200000
30 Sep 200000
30 Jun 200000
31 Mar 200000
31 Dec 190000

Quality Earnings: NPLS is currently unprofitable.

Growing Profit Margin: NPLS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NPLS is unprofitable, but has reduced losses over the past 5 years at a rate of 63.8% per year.

Accelerating Growth: Unable to compare NPLS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NPLS is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Services industry (37.6%).


Return on Equity

High ROE: NPLS has a negative Return on Equity (-17.92%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/11 20:26
End of Day Share Price 2024/07/15 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NP Life Sciences Health Industry Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution